tiprankstipranks
Trending News
More News >
PharmAla Biotech Holdings, Inc. (TSE:MDMA)
:MDMA
Canadian Market

PharmAla Biotech Holdings, Inc. (MDMA) Income Statement

Compare
63 Followers

PharmAla Biotech Holdings, Inc. Income Statement

Last quarter (Q3 2025), PharmAla Biotech Holdings, Inc.'s total revenue was C$135.17K, a decrease of -3.35% from the same quarter last year. In Q3, PharmAla Biotech Holdings, Inc.'s net income was C$-524.24K. See PharmAla Biotech Holdings, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21
Total Revenue
C$ 1.04MC$ 532.00KC$ 78.07KC$ 0.00
Gross Profit
C$ 887.44KC$ 454.10KC$ 75.78KC$ -303.00
Operating Expenses
C$ 1.53MC$ 1.22MC$ 1.06MC$ 2.51M
Depreciation and Amortization
C$ 70.21KC$ 52.77KC$ 12.13KC$ 303.00
EBITDA
C$ -573.36KC$ -710.18KC$ -973.45KC$ -2.51M
Operating Income
C$ -643.57KC$ -762.95KC$ -985.58KC$ -2.51M
Other Income/Expenses
C$ -180.03KC$ -16.86KC$ 0.00C$ 0.00
Pretax Income
C$ -823.60KC$ -779.81KC$ -985.58KC$ -2.51M
Net Income
C$ -823.60KC$ -779.81KC$ -985.58KC$ -2.51M
Per Share Metrics
Basic EPS
C$ -0.01C$ -0.01C$ -0.01C$ -0.03
Diluted EPS
C$ -0.01C$ -0.01C$ -0.01C$ -0.03
Weighted Average Shares Outstanding
88.57M 84.53M 83.00M 83.00M
Weighted Average Shares Outstanding (Diluted)
88.57M 84.53M 83.00M 83.00M
Currency in CAD

PharmAla Biotech Holdings, Inc. Earnings and Revenue History